Aghemo, Alessio

Publishing since 2005 (Junior)

Has published 22 publications in 6 years

Number of publications published per year by Aghemo, Alessio. (Source : PubMed)

Distribution of publications types for Aghemo, Alessio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Aghemo A, Colombo M. Peginterferon Alfa-2B versus peginterferon Alfa-2A with ribavirin for the treatment of chronic hepatitis C: the pursuit of an ideal.  Gastroenterology  2010;138;1  
•  Rumi MG, Aghemo A, Prati GM, D'Ambrosio R, Donato MF, Soffredini R, Del Ninno E, Russo A, Colombo M. Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.  Gastroenterology  2010;138;1  
•  De Nicola S, Aghemo A, Rumi MG, Colombo M. HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C.  J. Hepatol.  2009;51;5  
•  Aghemo A, Rumi MG, Colombo M. Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.  Expert Rev Anti Infect Ther  2009;7;8  
•  Aghemo A, Colombo M. Treatment of nonresponder patients with chronic hepatitis C: to repeat or not to repeat? That is the question.  Gastroenterology  2009;137;4  
•  Tripodi A, Chantarangkul V, Primignani M, Dell'Era A, Clerici M, Iannuzzi F, Aghemo A, Cazzaniga M, Salerno F, Mannucci PM. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.  J. Hepatol.  2009;51;2  
•  Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell'Era A, Mannucci PM. High levels of factor VIII and risk of extra-hepatic portal vein obstruction.  J. Hepatol.  2009;50;5  
•  Aghemo A, Colombo M. Cirrhosis regression in chronic hepatitis C: an old tale with a new ending.  Gastroenterology  2009;136;4  
•  Aghemo A, Colombo M. Cirrhosis regression in chronic hepatitis C: an old tale with a new ending.  Gastroenterology  2009;136;3  
•  Aghemo A, Rumi MG, Prati GM, Colombo M. The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?  Hepatology  2009;49;2  

[ See timeline ] [ See all publications ]